Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.

Current Alzheimer research - 1 Jan 2018

Vega Irving E, Umstead Andrew, Wygant Cassandra M, Beck John S, Counts Scott E

Abstract excerpt

BACKGROUND: The lack of diagnostic tools and disease-modifying treatments against Alzheimer's disease (AD) and related disorders, collectively known as tauopathies, has led to a socioeconomic burden of epidemic proportion. Proteomics approaches can be used to identify novel proteome changes that could help us understand the pathogenesis of tau-related pathological hallmarks and/or cellular stress responses...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognitive Dysfunction
Share to Cytoskeletal Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Electrophoresis, Gel, Two-Dimensional

Share to Mass Spectrometry

Share to Microarray Analysis

Share to Movement Disorders

Share to tau Proteins

Share to Tauopathies

Source

Open in PubMed Open full text

Identifiers

PMID: 30101710
DOI: 10.2174/1567205015666180813152043
PMCID: PMC6522142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.PMID 30101710Read ↗

Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice.Semantic proximity Read ↗

Proteostasis as a fundamental principle of Tau immunotherapySemantic proximity Read ↗

Common mouse models of tauopathy reflect early but not late human diseaseSemantic proximity Read ↗

Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau PathologySemantic proximity Read ↗

Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse modelSemantic proximity Read ↗

Expression of non-neuronal Tau in humans and miceSemantic proximity Read ↗

Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in TauopathySemantic proximity Read ↗

Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EBSemantic proximity Read ↗

Upregulation of RIN3 induces endosomal dysfunction in Alzheimer’s diseaseSemantic proximity Read ↗

Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.Semantic proximity Read ↗

Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice.Semantic proximity Read ↗

Expression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.